Does CD10 immunoexpression have a diagnostic utility in the differential diagnosis of renal oncocytomas and eosinophilic variants of chromophobe renal cell carcinomas?

Pathology

Volumn 41, Issue 2, 2009, Pages 191-193

  Mete, Ozgur ^a   Kilicaslan, Isin ^a   Uysal, Veli ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN;

CANCER DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY TUMOR; LETTER; ONCOCYTOMA; PROTEIN EXPRESSION;

EID: 61649121956     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020802579334     Document Type: Article

References (10)

1. Mete O, Kilicaslan I, Gulluoglu MG, Uysal V. Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin-1, CD63 and cytokeratin 14 antibodies in the differential diagnosis. Virchows Arch 2005; 447; 938-46.
2. Abrahams NA, MacLennan GT, Khoury JD, et al. Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue micoarray. Histopathology 2004; 45; 593-602.
3. Avery AK, Beckstead J, Renshaw AA, Corless CL. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol 2000; 24; 203-10.
4. Kim MK, Kim S. Immunohistochemical profile of common epithelial neoplasms arising in the kidney. Appl Immunohistochem Mol Morphol 2002; 10; 332-8.
5. Langner C, Ratschek M, Rehak P, et al. CD10 is a diagnostic and prognostic marker in renal malignancies. Histopathology 2004; 45; 460-7.
6. Martignoni G, Pea M, Brunelli M, et al. CD10 expression in a subset of chromophobe renal cell carcinomas. Mod Pathol 2004; 17; 1455-63.
7. Mazal PR, Stichenwirth M, Koller A, et al. Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study. Mod Pathol 2005; 18; 535-40.
8. Pan CC, Chen PCH, Ho DMT. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases. Histopathology 2004; 45; 452-9.
9. Wang HY, Mills S. KIT and RCC are useful in distinguishing chromophobe RCC from the granular variant of clear cell RCC. Am J Surg Pathol 2005; 29; 640-6.
10. Liu L, Qian J, Singh H, et al. Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: An optimal and practical panel for differential diagnosis. Arch Pathol Lab Med 2007; 131; 1290-7.